Abstract
The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Current Genomics
Title: p53 Gene Family: Structural, Functional and Evolutionary Features
Volume: 4 Issue: 1
Author(s): D'Erchia A. M., Tullo A., Pesole G., Saccone C. and Sbisa E.
Affiliation:
Abstract: The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Export Options
About this article
Cite this article as:
M. A. D'Erchia, A. Tullo, G. Pesole, C. Saccone and E. Sbisa, p53 Gene Family: Structural, Functional and Evolutionary Features, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350173
DOI https://dx.doi.org/10.2174/1389202033350173 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Ageing and Apoptosis
Current Pharmaceutical Design Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry Functional Consequences of Immune Cell Adhesion to Endothelial Cells
Current Pharmaceutical Design Pharmacogenetics and the Pharmaceutical Industry
Current Pharmaceutical Design Targeting Notch Pathway in Cancer Diagnostics and Therapeutics: An Emerging Approach
Recent Patents on Anti-Cancer Drug Discovery Diet-Derived Phytochemicals: From Cancer Chemoprevention to Cardio-Oncological Prevention
Current Drug Targets Immunomodulation Via Targeted Inhibition of Antigen Receptor Signal Transduction
Cardiovascular & Hematological Disorders-Drug Targets Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Current Pharmaceutical Design Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway
Current Neurovascular Research Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Cytotoxic Effects on B Lymphocytes Mediated by Reactive Oxygen Species
Current Pharmaceutical Design Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
Current Cancer Drug Targets Daphnane-Type Diterpene Orthoesters and their Biological Activities
Mini-Reviews in Medicinal Chemistry Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Current Topics in Medicinal Chemistry Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment
Current Pharmaceutical Design Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient
Current Cancer Therapy Reviews The Genetic Basis of New Treatment Modalities in Melanoma
Current Drug Targets Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry